Quick Takeaways
- RPRX - Royalty Pharma plc has 25 insiders with reported activity on this page.
- Net insider value flow over the last year: -$57,734,381.
- Recent transaction rows are available for direct filing-level review.
- Info
- Portfolio
- Insider Ownership
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 25 Insiders of Royalty Pharma plc
- Symbol
- RPRX on Nasdaq
- Location
- New York, NY
What Changed
- Buy value: ; sell value: $57,734,381.
- Net share flow: -1,432,286.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$57,734,381.
Buys
$0
Shares: 0
Insiders: 0
Sells
$57,734,381
Shares: 1,432,286
Insiders: 4
Net
-$57,734,381
Shares: -1,432,286
Insiders: -4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 512,287 | $0 | $21,985,661 | -$21,985,661 |
| 3-6 | 0 | 886,499 | $0 | $34,534,972 | -$34,534,972 |
| 6-9 | 0 | 33,500 | $0 | $1,213,749 | -$1,213,749 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Royalty Pharma plc executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Pablo G. Legorreta | CEO, Chairman of the Board, Director | $2,778,081,474 | Mixed | 11 Feb 2026 | ||
| GG 1978 SICAF SIF S.A. | 10%+ Owner | $608,282,853 | Mixed | 14 Sep 2022 | ||
| GG 1978 SICAF SIF S.A. - GG Strategic | 10%+ Owner | $590,239,561 | Mixed | 20 Sep 2022 | ||
| George W. Lloyd | EVP, Investments & CLO | $300,616,992 | -$13,807,997 | -4.4% | Mixed | 17 Dec 2025 |
| Terrance P. Coyne | Evp & Cfo | $236,671,194 | -$33,102,400 | -12% | Mixed | 01 Apr 2026 |
| Mario Germano Giuliani | Director, 10%+ Owner | $96,010,741 | Mixed | 23 Jun 2023 | ||
| William E. Ford | Director | $71,241,786 | Mixed | 30 Jun 2021 | ||
| Avara Management Ltd | 10%+ Owner | $68,463,141 | Mixed | 29 Dec 2023 | ||
| Christopher Hite | EVP & Vice Chairman | $29,178,455 | Mixed | 11 Feb 2026 | ||
| James F. Reddoch | EVP & Chief Scientific Officer | $23,300,586 | Mixed | 28 Sep 2022 | ||
| Rory B. Riggs | Director | $11,577,870 | Mixed | 20 Feb 2024 | ||
| Gregory Norden | Director | $7,059,596 | -$1,213,749 | -15% | Filing P/S | 08 Aug 2025 |
| Errol B. Desouza | Director | $4,828,170 | Mixed | 13 May 2025 | ||
| Henry A. Fernandez | Director | $4,190,575 | Mixed | 30 Jun 2025 | ||
| Ted W. Love | Director | $3,118,018 | Mixed | 13 May 2025 | ||
| Catherine M. Engelbert | Director | $2,948,893 | Mixed | 13 May 2025 | ||
| Bonnie L. Bassler | Director | $2,857,312 | Mixed | 31 Mar 2026 | ||
| David C. Hodgson | Director | $1,842,120 | Mixed | 13 May 2025 | ||
| Marshall Urist | EVP, Research & Investments | $1,792,431 | -$9,610,236 | -84% | Mixed | 11 Feb 2026 |
| Vlad Coric | Director | $344,996 | Mixed | 13 May 2025 | ||
| Attached Carole Ho | Director | $306,718 | Mixed | 31 Jul 2025 | ||
| Elizabeth H. Weatherman | Director | $306,718 | Mixed | 31 Jul 2025 | ||
| Royalty Pharma plc | Director | $0 | Mixed | 07 Apr 2025 | ||
| Arthur R. McGivern | EVP, Investments & GC | Mixed | 01 Jan 2026 | |||
| MGG Strategic SICAF SIF S.A. | 10%+ Owner | Mixed | 01 Apr 2022 |
Top shareholders of Royalty Pharma plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Pablo G. Legorreta |
13D/G
3/4/5
|
Legorreta G. Pablo · CEO, Chairman of the Board, Director |
20%
|
103,112,796
|
$3,372,819,557 | $0 | 16 May 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
9.2%
from 13D/G
|
55,274,069
|
$2,135,790,095 | — | 31 Dec 2025 | |
| Capital International Investors |
13D/G
13F
|
Company |
7.7%
|
32,745,526
|
$1,265,287,125 | +$163,578,499 | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
26,272,308
|
$1,015,161,996 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.7%
from 13D/G
|
26,188,692
|
$1,011,931,068 | — | 31 Dec 2025 | |
| Severgnini Achille G. |
13D/G
|
— |
5.7%
|
24,223,082
|
$978,612,513 | -$230,404,755 | 06 Nov 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
4%
|
17,008,768
|
$657,218,795 | — | 31 Dec 2025 | |
| GG 1978 SICAF SIF S.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
22,081,156
|
$608,282,853 | — | 14 Sep 2022 | |
| GG 1978 SICAF SIF S.A. - GG Strategic |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
21,426,170
|
$590,239,561 | — | 20 Sep 2022 | |
| GENERAL ATLANTIC, L.P. |
13D/G
|
— |
3.2%
|
14,243,870
|
$510,500,301 | $0 | 30 Jun 2025 | |
| Swedbank AB |
13F
|
Company |
2.8%
|
11,942,143
|
$461,444,406 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.8%
|
11,740,594
|
$453,656,552 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
10,649,641
|
$411,502,128 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
2.5%
|
10,936,538
|
$385,841,061 | $0 | 30 Sep 2025 | |
| George W. Lloyd |
3/4/5
|
EVP, Investments & CLO |
—
mixed-class rows
|
3,477,118
mixed-class rows
|
$300,616,992 | -$13,807,997 | 17 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
7,719,843
|
$297,465,419 | — | 31 Dec 2025 | |
| Caledonia (Private) Investments Pty Ltd |
13F
|
Company |
1.7%
|
7,377,038
|
$285,048,748 | — | 31 Dec 2025 | |
| Terrance P. Coyne |
3/4/5
|
EVP & CFO |
—
mixed-class rows
|
2,577,412
mixed-class rows
|
$236,671,194 | -$33,102,400 | 01 Apr 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
5,273,865
|
$203,782,144 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
5,106,905
|
$197,330,809 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.2%
|
4,947,409
|
$191,167,884 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.94%
|
4,003,322
|
$154,688,363 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
0.8%
|
3,414,165
|
$131,923,336 | — | 31 Dec 2025 | |
| Patient Capital Management, LLC |
13F
|
Company |
0.78%
|
3,333,675
|
$128,813,194 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.78%
|
3,313,265
|
$128,024,560 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.73%
|
3,118,865
|
$120,512,944 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.73%
|
3,088,098
|
$119,324,106 | — | 31 Dec 2025 | |
| NEW SOUTH CAPITAL MANAGEMENT INC |
13F
|
Company |
0.69%
|
2,928,778
|
$113,167,982 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
2,913,398
|
$112,573,699 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.64%
|
2,708,925
|
$104,672,844 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.63%
|
2,679,379
|
$103,531,205 | — | 31 Dec 2025 | |
| Regal Partners Ltd |
13F
|
Company |
0.62%
|
2,640,708
|
$102,036,956 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
2,563,654
|
$99,059,574 | — | 31 Dec 2025 | |
| Mario Germano Giuliani |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
3,485,267
|
$96,010,741 | — | 23 Jun 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.58%
|
2,469,181
|
$95,409,154 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.54%
|
2,312,128
|
$89,353,846 | — | 31 Dec 2025 | |
| Dorsey Asset Management, LLC |
13F
|
Company |
0.53%
|
2,259,469
|
$87,305,882 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.51%
|
2,185,079
|
$84,431,452 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.47%
|
2,005,831
|
$77,505,310 | — | 31 Dec 2025 | |
| William E. Ford |
3/4/5
|
Director |
—
class O/S missing
|
2,586,134
|
$71,241,786 | — | 30 Jun 2021 | |
| Avara Management Ltd |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,485,267
|
$68,463,141 | — | 29 Dec 2023 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.42%
|
1,764,269
|
$68,171,354 | — | 31 Dec 2025 | |
| Clark Capital Management Group, Inc. |
13F
|
Company |
0.41%
|
1,753,810
|
$67,767,222 | — | 31 Dec 2025 | |
| HOMESTEAD ADVISERS CORP |
13F
|
Company |
0.39%
|
1,671,542
|
$64,588,383 | — | 31 Dec 2025 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.37%
|
1,579,252
|
$61,022,297 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.37%
|
1,556,241
|
$60,133,152 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
1,550,900
|
$59,926,777 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.36%
|
1,518,610
|
$58,679,167 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.35%
|
1,502,171
|
$58,043,882 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.35%
|
1,467,599
|
$56,760,405 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Royalty Pharma plc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -50% | $1,590,890 | $48.33 | -32,916 | 32,916 | 01 Apr 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.27% | $90,622 | $48.33 | -1,875 | 42,011 | 01 Apr 2026 | TPC RP EPA1 LLC |
| Bonnie L. Bassler | RPRX | Class A Ordinary Shares | Award | 1.11% | 815 | 73,947 | 31 Mar 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.1% | $85,366 | $45.53 | -1,875 | 43,886 | 23 Mar 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -33.3% | $1,498,623 | $45.53 | -32,916 | 65,832 | 23 Mar 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -3.94% | $87,713 | $46.78 | -1,875 | 45,761 | 02 Mar 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -25% | $1,539,821 | $46.78 | -32,916 | 98,748 | 02 Mar 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -3.79% | $84,968 | $45.32 | -1,875 | 47,636 | 23 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -20% | $1,491,638 | $45.32 | -32,916 | 131,664 | 23 Feb 2026 | By TPC RP 2021, LLC |
| Pablo G. Legorreta | RPRX | Class A Ordinary Shares | Award | 16.8% | 157,828 | 1,098,783 | 11 Feb 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Award | 116.4% | 26,626 | 49,511 | 11 Feb 2026 | TPC RP EPA1 LLC | ||
| Christopher Hite | RPRX | Class A Ordinary Shares | Award | 4.04% | 26,626 | 685,136 | 11 Feb 2026 | By SCH Investment Partners LLC | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Award | 269.9% | 19,970 | 27,368 | 11 Feb 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.53% | $47,059 | $43.29 | -1,087 | 22,885 | 04 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -10.4% | $825,853 | $43.29 | -19,076 | 164,580 | 04 Feb 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -20.5% | $265,413 | $42.84 | -6,195 | 23,972 | 03 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -37.2% | $4,659,584 | $42.84 | -108,759 | 183,656 | 03 Feb 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -16.2% | $245,896 | $42.08 | -5,843 | 30,167 | 02 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -26% | $4,317,009 | $42.08 | -102,581 | 292,415 | 02 Feb 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -100% | $821,810 | $41.09 | -20,000 | 0 | 30 Jan 2026 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -50% | $805,110 | $40.26 | -20,000 | 20,000 | 23 Jan 2026 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -9.43% | $147,556 | $39.35 | -3,750 | 36,010 | 20 Jan 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -14.3% | $2,590,384 | $39.35 | -65,832 | 394,996 | 20 Jan 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -33.3% | $790,346 | $39.52 | -20,000 | 40,000 | 16 Jan 2026 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -25% | $815,634 | $40.78 | -20,000 | 60,000 | 09 Jan 2026 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -8.62% | $144,059 | $38.42 | -3,750 | 39,760 | 02 Jan 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -12.5% | $2,528,982 | $38.42 | -65,832 | 460,828 | 02 Jan 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -20% | $769,650 | $38.48 | -20,000 | 80,000 | 02 Jan 2026 | By Sandy Lamm LLC |
| Bonnie L. Bassler | RPRX | Class A Ordinary Shares | Award | 1.34% | 967 | 73,132 | 31 Dec 2025 | Direct | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -16.7% | $786,380 | $39.32 | -20,000 | 100,000 | 26 Dec 2025 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -14.3% | $767,582 | $38.38 | -20,000 | 120,000 | 19 Dec 2025 | By Sandy Lamm LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -100% | $1,180,053 | $38.50 | -30,654 | 0 | 18 Dec 2025 | By GWL 2014 G, LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -72.1% | $3,060,280 | $38.57 | -79,346 | 30,654 | 17 Dec 2025 | By GWL 2014 G, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -12.5% | $766,420 | $38.32 | -20,000 | 140,000 | 16 Dec 2025 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -7.93% | $143,850 | $38.36 | -3,750 | 43,510 | 15 Dec 2025 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -11.1% | $2,525,322 | $38.36 | -65,832 | 526,660 | 15 Dec 2025 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -71.2% | $714,224 | $39.15 | -18,242 | 7,398 | 05 Dec 2025 | Direct |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -12.7% | $913,591 | $39.15 | -23,334 | 160,000 | 05 Dec 2025 | By Sandy Lamm LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -50% | $4,375,008 | $39.77 | -110,000 | 110,000 | 03 Dec 2025 | By GWL 2014 G, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -7.35% | $149,498 | $39.87 | -3,750 | 47,260 | 01 Dec 2025 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -10% | $2,624,459 | $39.87 | -65,832 | 592,492 | 01 Dec 2025 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -41.6% | $727,856 | $39.90 | -18,242 | 25,640 | 01 Dec 2025 | Direct |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -11.3% | $931,633 | $39.93 | -23,333 | 183,334 | 01 Dec 2025 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -6.85% | $144,569 | $38.55 | -3,750 | 51,010 | 24 Nov 2025 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -9.09% | $2,537,937 | $38.55 | -65,832 | 658,324 | 24 Nov 2025 | By TPC RP 2021, LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -100% | $115,029 | $38.34 | -3,000 | 0 | 19 Nov 2025 | Direct |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -100% | $1,073,607 | $38.34 | -28,000 | 0 | 19 Nov 2025 | By GWL 2021 G, LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -100% | $1,993,842 | $38.34 | -52,000 | 0 | 19 Nov 2025 | By GWL 2020 G, LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -89.6% | $2,010,178 | $38.34 | -52,426 | 6,084 | 19 Nov 2025 | By GWL 2023 G HoldCo LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -6.41% | $147,390 | $39.30 | -3,750 | 54,760 | 17 Nov 2025 | TPC RP EPA1 LLC |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.